Generic Name: Eltrombopag
Brand Name: Revolade
Manufacturer: GlaxoSmithKline
Indications: Thrombocytopenia associated with chronic hepatitis c infection
Submission Type: New Indication
Project Status: Complete
Date Recommendation Issued: March 18, 2015
Recommendation Type: List with criteria/condition